Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-042291

SVP and General Counsel sold 4,166 shares at $40.00 ($166,640)

  • SVP and General Counsel acquired 4,166 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Taylor Stacy L SVP and General Counsel 2021-06-17 Option exercise +1,041 $7.80 $8,120 16,077 D: show line 1 in the form
Taylor Stacy L SVP and General Counsel 2021-06-17 Option exercise +1,771 $6.55 $11,600 17,848 D: show line 2 in the form
Taylor Stacy L SVP and General Counsel 2021-06-17 Option exercise +1,354 $31.71 $42,935 19,202 D: show line 3 in the form
Taylor Stacy L SVP and General Counsel 2021-06-17 Sale −4,166 $40.00 $166,640 15,036 D: show line 4 in the form
Open-market sales · 4,166 sh · avg $40.00 · $166,640

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Taylor Stacy L SVP and General Counsel 2021-06-17 Option exercise · Stock Option (Right to Buy) −1,041 23,959 D: show line 5 in the form
Taylor Stacy L SVP and General Counsel 2021-06-17 Option exercise · Stock Option (Right to Buy) −1,771 17,709 D: show line 6 in the form
Taylor Stacy L SVP and General Counsel 2021-06-17 Option exercise · Stock Option (Right to Buy) −1,354 44,688 D: show line 7 in the form
Loading xslF345X03/doc4.xml…